Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Clinical trial NCT00423735 · COMPLETED

Trial details

NCT number: NCT00423735
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Recurrent Adult Brain Neoplasm

Start date: 2007-01-24
Primary completion: 2011-03-09
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.